A

ATUM

North America, California, United States, Newark

Description

ATUM is a biotechnology company that provides tools for the life sciences.

Investor Profile

ATUM has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Medical.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ATUM frequently co-invest with?

Ampersand Capital Partners
North America, Massachusetts, United States, Wellesley
Co-Investments: 1
Seagull Capital
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1
Dynamk Capital
North America, New York, United States, New York
Co-Investments: 1
PV
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 1
PR
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 1
Echo Investment Capital
North America, Oklahoma, United States, Oklahoma City
Co-Investments: 1
Charles River Laboratories International
North America, Massachusetts, United States, Wilmington
Co-Investments: 2
Alloy Therapeutics
North America, Massachusetts, United States, Waltham
Co-Investments: 2

What are some of recent deals done by ATUM?

Wheeler Bio

Oklahoma City, Oklahoma, United States

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

BiotechnologyLife ScienceTherapeutics
Series AOct 4, 2022
Amount Raised: $31,000,000
Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical
Series AJun 2, 2022
Amount Raised: $21,000,000